共 107 条
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function
被引:251
作者:
Milligan, Graeme
[1
]
机构:
[1] Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland
基金:
英国医学研究理事会;
英国惠康基金;
英国生物技术与生命科学研究理事会;
关键词:
G protein-coupled receptor;
G protein;
dimerization;
receptor pharmacology;
RESONANCE ENERGY-TRANSFER;
MU-OPIOID RECEPTORS;
CELL-SURFACE;
GPCR OLIGOMERIZATION;
MOLECULAR-BASIS;
DRUG TARGETS;
IN-VIVO;
ALPHA(1D)-ADRENERGIC RECEPTORS;
BETA(2)-ADRENERGIC RECEPTORS;
DOPAMINE-D-2;
RECEPTORS;
D O I:
10.1111/j.1476-5381.2009.00169.x
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The concept that G protein-coupled receptors (GPCRs) can form hetero-dimers or hetero-oligomers continues to gain experimental support. However, with the exception of the GABAB receptor and the sweet and umami taste receptors few reported examples meet all of the criteria suggested in a recent International Union of Basic and Clinical Pharmacology sponsored review (Pin et al., 2007) that should be required to define distinct and physiologically relevant receptor species. Despite this, there are many examples in which pairs of co-expressed GPCRs reciprocally modulate their function, trafficking and/or ligand pharmacology. Such data are at least consistent with physical interactions between the receptor pairs. In recent times, it has been suggested that specific GPCR hetero-dimer or hetero-oligomer pairs may represent key molecular targets of certain clinically effective, small molecule drugs and there is growing interest in efforts to identify ligands that may modulate hetero-dimer function selectively. The current review summarizes key recent developments in these topics. British Journal of Pharmacology (2009) 158, 5-14; doi:10.1111/j.1476-5381.2009.00169.x; published online 20 March 2009
引用
收藏
页码:5 / 14
页数:10
相关论文